Transgene Biotek Ltd
Transgene Biotek Ltd (526139): company summary
Transgene Biotek Ltd (526139) is a micro-cap Healthcare Services company valued at ₹23 crore operating in Healthcare Service Provider on the NSE and BSE.
Transgene Biotek Ltd (526139) is a micro-cap Healthcare Services company valued at ₹23 crore operating in Healthcare Service Provider on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 51.8% a year over three years. Return on equity is -17.9%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 2.69 times book value.
- Things to watch
- Debt is 2.05 times equity.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Held back by quality (0.0). Scored on 4 of 5 measures.
DocStoX score
Low confidenceScored on 4 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Loss-making — no meaningful P/E
- High leverage — debt is 2.0× equity
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare Services stocks · Healthcare Service Provider
Explore Transgene Biotek Ltd’s valuation
Free deep-dive tools · no sign-up
Transgene Biotek Ltd peers in Healthcare Services
Other Healthcare Services stocks on the NSE & BSE. See the full Healthcare Services sector list.
Related tools & concepts
Value Transgene Biotek Ltd with the ratios and calculators DocStoX uses in its analysis.

